TY  - GEN
AU  - Martin,Miguel
AU  - Brase,Jan C
AU  - Calvo,Lourdes
AU  - Krappmann,Kristin
AU  - Ruiz-Borrego,Manuel
AU  - Fisch,Karin
AU  - Ruiz,Amparo
AU  - Weber,Karsten E
AU  - Munarriz,Blanca
AU  - Petry,Christoph
AU  - Rodriguez,Cesar A
AU  - Kronenwett,Ralf
AU  - Crespo,Carmen
AU  - Alba,Emilio
AU  - Carrasco,Eva
AU  - Casas,Maribel
AU  - Caballero,Rosalia
AU  - Rodriguez-Lescure,Alvaro
TI  - Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial
SN  - 1465-542X
PY  - 2015///0206
KW  - Antineoplastic Agents, Hormonal
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Clinical Trials, Phase III as Topic
KW  - Cyclophosphamide
KW  - Epirubicin
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Lymphatic Metastasis
KW  - Multicenter Studies as Topic
KW  - Outcome Assessment, Health Care
KW  - methods
KW  - Paclitaxel
KW  - Prospective Studies
KW  - Randomized Controlled Trials as Topic
KW  - Receptor, ErbB-2
KW  - metabolism
KW  - Receptors, Estrogen
KW  - Reproducibility of Results
KW  - Retrospective Studies
N1  - Publication Type: Journal Article; Validation Study
UR  - https://doi.org/10.1186/bcr3642
ER  -